Top Ranked Momentum Stocks to Buy for July 13th

CACI KOS BLFS

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 13th:

BioLifeSolutions, Inc. (BLFS - Free Report) : This developer of medical products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

BioLife Solutions, Inc. Price and Consensus

BioLifeSolutions’ shares gained 68.6% over the last one month more than S&P 500’s gain of 0.8%. The company possesses a Momentum Score of A.

BioLife Solutions, Inc. Price

Kosmos Energy Ltd. (KOS - Free Report) : This oil exploration and production company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings climbing more than 100% over the last 60 days.

Kosmos Energy Ltd. Price and Consensus

Kosmos’ shares gained 4.3% over the last one month. The company possesses a Momentum Score of A.

Kosmos Energy Ltd. Price

CACI International Inc (CACI - Free Report) : This provider of information solutions has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.2% over the last 60 days.

CACI International, Inc. Price and Consensus

CACI’s shares gained 7.9% over the last one month. The company possesses a Momentum Score of B.

CACI International, Inc. Price

Advanced Disposal Services, Inc. : This provider of non-hazardous solid waste collection and recycling services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5% over the last 60 days.

Advanced Disposal Services Inc. Price and Consensus

Advanced Disposal’s shares gained 8.1% over the last one month. The company possesses a Momentum Score of A.

Advanced Disposal Services Inc. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>